This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Google Creates Venture Capital Fund In London To Back European Startups

Google is starting a venture capital arm in Europe, hoping to find the next Skype or Spotify early.

Holder Refuses to Meet With BofA's Moynihan Over Mortgage Settlement

Attorney General Eric Holder has formally refused to meet with Bank of America CEO Brian Moynihan as they try to negotiate a multi-billion-dollar deal.

American Apparel Shakes Up Board To Get $25 Million In Rescue Fund

American Apparel reached a deal with its biggest investor, Standard General.

Rooster Infertility Drives Up Price of Chicken: Crisis at the Coop

Aviagen Group, the largest producer of breeding chickens, has found that tweaking the genes of its mainstay rooster has rendered the crowing male chickens less fertile.

Allergan CEO David Pyott Hunting Acquisitions to Fend Off Valeant

Allergan CEO is looking at potential sizable acquisitions as he seeks to fend off a $53 billion hostile takeover offer from Valeant Pharmaceuticals.

Real Money Previews

Cramer: Valeant Is Hard to Stop

Cheap money and greed from the Allergan bidder's side are strong incentives.

Cramer: What to Buy in the Selloff

Here are several themes that are still working -- and now you can get in at a bargain.

Cramer: I Bet It Was One Big Seller

Some large account could have liquidated positions yesterday.

Mad Money Recap

'Mad Money' Lightning Round: AT&T Is a Buy

Cramer wants to own WhiteWave Foods, likes Johnson & Johnson over Pfizer and wants you to stay away from Gogo.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Big Trades to Conquer a Correcting Market

If this morning's early price action is any indication, investors are in for a rough ride.

4 Stocks Rising on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

3 Big-Volume Stocks in Breakout Territory

These stocks rising on unusual volume are within range of triggering breakout trades.

3 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

4 Hot Stocks to Trade (or Not)

Here's how to trade some of the most active stocks on the market today.

MainStreet

Parents Don't Want to Talk Money With Their Adult Children

Older Americans are putting off talking about retirement preparedness, eldercare and estate planning, and Fidelity says it's not helping.

Should You Skip Mid-Year Rebalancing?

Stocks kept climbing this year, surprising many, but does a chance to keep riding a wave change standard rebalancing plans?

Our Sugar Consumption Is Out of Control, Author Says

Sugar is as addicting as cocaine, J.J. Virgin says in an upcoming book, and our consumption just jumped 23% in only a decade.

Beer Mailbag: New Belgium, Woodchuck Send Off Summer

The summer beer season will be over by the end of July, but limited edition seasonal offering and collaborations will stay around until then.

5 Things Your Micro-Manager Boss Needs to Hear

Why would an employer or boss intentionally get in the way of employee enthusiasm and productivity? While there's no answer, there may be a cure.

Biotech

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

Healthcare investors (and traders) have had a lot to work with so far this year, and the next six months promises to be equally action packed.

Latest Sarepta Study Update Shows Greater Decline in Walking Ability

Even with greater decline in walk performance after almost three years, Duchenne boys treated with eteplirsen are still benefiting from treatment, Sarepta says.

Radient Pharma: RIP

The SEC halts trading in Radient Pharmaceuticals.

Beyond Wall St.

Deal News

Family Dollar Tries Beer and Wine to Fight Sales Hangover

Family Dollar CEO Howard Levine said on Thursday he believes a turnaround of the struggling company is taking hold.

IPO Market Surges Enticing Investors Starved for Yield

The IPO market has been booming on strong equity markets and investors starving for yield.

Standard General Rides to American Apparel's Rescue

American Apparel said it was pulling back from the brink of defaulting on its debt, thanks to $25 million in immediate financial support from New York hedge fund Standard General.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Valeant Is Hard to Stop

Cheap money and greed from the Allergan bidder's side are strong incentives.

Herb Greenberg

Greenberg: No Surprise in Potbelly's Flop

Potbelly was one of those disasters you could see coming. Ever since its IPO, its stock has done little more than head lower, and for good reason.

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Apple TV Races to Regain Past Dominance as Roku, Google Take Lead

Apple has lost market share in the domestic set-top box business, according to research firm Parks Associates, putting the world's largest company behind Roku and its largest rival...

Adam Feuerstein

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

Healthcare investors (and traders) have had a lot to work with so far this year, and the next six months promises to be equally action packed.

Laurie Kulikowski

Lululemon Jumps on Report Wilson Talking to Private Equity

Lululemon Athletica was rising 2.1% to $42.29 after The Wall Street Journal reported that founder Dennis "Chip" Wilson was talking to PE firms about taking the yoga apparel maker p...

Dan Freed

Barclays Charged With Fraud Over 'Dark Pool'

Barclays Capital committed fraud tied to a private, internal stock trading platform known as a 'dark pool,' according to charges filed Wednesday by New York Attorney General Eric S...

Rocco Pendola

Apple Well On Its Way to Absolutely Devastating Microsoft

Recent data suggests a scary conclusion for Microsoft -- business customers might be moving away from Windows/Office pursuant to employee demand.

Ted Reed

Delta Raises Doubts and Skittish Airline Investors Keep Selling

Delta disappointed airline investors on July 2, and the selling continued into Monday morning.

Leon Lazaroff

Aereo Loses as Supreme Court Rules Service Violates Copyright Law

Aereo's future was put in doubt as the Supreme Court ruled that the video-streaming service violates U.S. copyright law.

Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs